RICE HALL JAMES & ASSOCIATES, LLC - UTAH MED PRODS INC ownership

UTAH MED PRODS INC's ticker is UTMD and the CUSIP is 917488108. A total of 75 filers reported holding UTAH MED PRODS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
RICE HALL JAMES & ASSOCIATES, LLC ownership history of UTAH MED PRODS INC
ValueSharesWeighting
Q3 2023$9,600,524
-8.8%
111,634
-1.2%
0.61%
+2.0%
Q2 2023$10,531,468
-2.6%
112,999
-1.0%
0.60%
-2.6%
Q1 2023$10,815,446
-5.9%
114,123
-0.2%
0.61%
-6.8%
Q4 2022$11,497,214
+14.7%
114,366
-2.7%
0.66%
+13.4%
Q3 2022$10,027,000
-1.8%
117,538
-1.1%
0.58%
+17.6%
Q2 2022$10,213,000
-2.5%
118,890
+2.0%
0.49%
+18.2%
Q1 2022$10,479,000
-7.9%
116,613
+2.4%
0.42%
+3.5%
Q4 2021$11,383,000
+6.8%
113,833
-0.8%
0.40%
+2.5%
Q3 2021$10,657,000
+11.0%
114,785
+1.7%
0.39%
+15.5%
Q2 2021$9,600,000
-5.3%
112,889
-3.5%
0.34%
+3.3%
Q1 2021$10,132,000
+15.5%
116,996
+12.4%
0.33%
+6.8%
Q4 2020$8,774,000
+10.5%
104,075
+4.7%
0.31%
-3.4%
Q3 2020$7,943,000
+24.0%
99,447
+37.6%
0.32%
+16.4%
Q2 2020$6,406,000
-4.9%
72,284
+0.9%
0.28%
-26.9%
Q1 2020$6,735,000
-22.8%
71,614
-11.4%
0.38%
+27.5%
Q4 2019$8,725,000
+15.8%
80,866
+2.9%
0.30%
+9.7%
Q3 2019$7,535,000
+0.9%
78,619
+0.7%
0.27%
+8.5%
Q2 2019$7,470,000
+88.2%
78,053
+73.5%
0.25%
+93.8%
Q1 2019$3,970,000
+102.7%
44,989
+90.8%
0.13%
+80.3%
Q4 2018$1,959,000
+510.3%
23,582
+591.8%
0.07%
+545.5%
Q3 2018$321,000
-14.9%
3,409
-0.4%
0.01%
-21.4%
Q2 2018$377,000
+13.6%
3,421
+1.7%
0.01%
+7.7%
Q1 2018$332,000
+5.4%
3,363
-13.1%
0.01%
+8.3%
Q4 2017$315,000
+11.7%
3,872
+1.1%
0.01%0.0%
Q3 2017$282,000
+1.8%
3,831
+0.1%
0.01%0.0%
Q2 2017$277,000
+17.4%
3,829
+1.1%
0.01%
+9.1%
Q1 2017$236,000
-11.6%
3,789
+3.1%
0.01%
-15.4%
Q4 2016$267,0003,6750.01%
Other shareholders
UTAH MED PRODS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Clean Yield Group 49,094$3,535,0001.48%
MORGAN DEMPSEY CAPITAL MANAGEMENT LLC 27,464$1,988,0000.72%
Ativo Capital Management LLC 16,525$1,196,0000.33%
Ancora Advisors LLC 55,159$3,993,0000.26%
ISTHMUS PARTNERS, LLC 10,754$779,0000.23%
Cardinal Capital Management 9,180$665,0000.22%
Acrospire Investment Management LLC 1,919$139,0000.13%
Penobscot Investment Management Company, Inc. 4,000$290,0000.09%
TFS CAPITAL LLC 3,226$234,0000.09%
WCM INVESTMENT MANAGEMENT, LLC 81,912$5,930,0000.09%
View complete list of UTAH MED PRODS INC shareholders